A prospective, randomized, controlled trial of an emergency department-based atrial fibrillation treatment strategy with low-molecular-weight heparin

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Compared with the standard care provided to low-risk patients with newly diagnosed or new-onset atrial fibrillation (AF), the clinical pathway was effective in reducing hospital stay and it showed a trend towards a reduction in the costs.